S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity
- Dev Cell. 2021 Oct 25;56(20):2790-2807.e8. doi: 10.1016/j.devcel.2021.09.016.
- 1. Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland. Electronic address: [email protected].
- 2. Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland.
- 3. Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL, USA.
- 4. Institute of Bioengineering, School of Life Sciences, EPFL, Lausanne, Switzerland.
- 5. Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland. Electronic address: [email protected].
SARS-CoV-2 virions are surrounded by a lipid bilayer that contains membrane proteins such as spike, responsible for target-cell binding and virus fusion. We found that during SARS-CoV-2 Infection, spike becomes lipid modified, through the sequential action of the S-acyltransferases ZDHHC20 and 9. Particularly striking is the rapid acylation of spike on 10 cytosolic cysteines within the ER and Golgi. Using a combination of computational, lipidomics, and biochemical approaches, we show that this massive lipidation controls spike biogenesis and degradation, and drives the formation of localized ordered Cholesterol and sphingolipid-rich lipid nanodomains in the early Golgi, where viral budding occurs. Finally, S-acylation of spike allows the formation of viruses with enhanced fusion capacity. Our study points toward S-acylating Enzymes and lipid biosynthesis Enzymes as novel therapeutic anti-viral targets.